🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed problematic content and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After moments of joining one community, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, posts show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly serious health risks”.